Gustave Roussy, INSERM, Villejuif, France; Institut Necker des Enfants Malades (INEM), INSERM, CNRS, Université Paris Cité, Paris, France.
Gustave Roussy, INSERM, Villejuif, France.
Cancer Cell. 2024 May 13;42(5):747-758. doi: 10.1016/j.ccell.2024.04.002. Epub 2024 Apr 25.
Cancer is a progressive disease that can develop and evolve over decades, with inflammation playing a central role at each of its stages, from tumor initiation to metastasis. In this context, macrophages represent well-established bridges reciprocally linking inflammation and cancer via an array of diverse functions that have spurred efforts to classify them into subtypes. Here, we discuss the intertwines between macrophages, inflammation, and cancer with an emphasis on temporal dynamics of macrophage diversity and functions in pre-malignancy and cancer. By instilling temporal dynamism into the more static classic view of tumor-associated macrophage biology, we propose a new framework to better contextualize their significance in the inflammatory processes that precede and result from the onset of cancer and shape its evolution.
癌症是一种渐进性疾病,可在数十年内发展和演变,炎症在其各个阶段(从肿瘤起始到转移)都起着核心作用。在这种情况下,巨噬细胞通过一系列不同的功能成为炎症和癌症之间相互联系的桥梁,这些功能促使人们努力将其分为不同的亚型。在这里,我们讨论了巨噬细胞、炎症和癌症之间的相互关系,重点讨论了巨噬细胞多样性和功能在癌前病变和癌症中的时间动态。通过为肿瘤相关巨噬细胞生物学的更静态经典观点注入时间动态性,我们提出了一个新的框架,以更好地将它们在癌症发生之前和之后的炎症过程中的意义置于上下文中,并塑造其演变。